概览
Advanced registraion has been closed.
Please come to the on-site Registration Desk if you would like to attend.
This symposium will be conducted in Japanese Language.
Featured
Want to learn more about 2nd Medical Communication Workshop? You've come to the right site!
项目委员会
-
Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
MSD K.K., Japan -
Yuko Kojima, RPH Sr. Executive Director
Eli Lilly Japan K.K., Japan -
Rika Abe, RPH Research Administrator, Office of the Fugaku Society 5.0 Initiative
RIKEN Center for Computational Science, Japan -
Yasufumi Kuroda, PHD Senior Director
Daiichi Sankyo Company, Limited, Japan -
Hiroki Nagahama, MS Director, Japan Safety Risk Management Lead, Clinical Safety & Pharmacovigilance
GlaxoSmithKline K.K., Japan -
Shohko Sekine Reviewer, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Naoko Tejima Group Manager, Regulatory Writing & Operations Group, Regulatory Affairs
Astellas Amgen Biopharma, Japan -
Seiki Yamazaki Director, Clinical Informatics & Innovation
Pfizer Japan Inc., Japan -
Hideo Nakada, RPH Deputy Associate Manager, Department of Hospital Pharmacy
Keio University, Japan
